4.7 Article

Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 144, Issue -, Pages 557-571

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2017.12.055

Keywords

beta-Carbolines; Podophyllotoxin; Topoisomerase II inhibition; Cytotoxicity; Docking

Funding

  1. Council of Scientific and Industrial Research (CSIR), New Delhi (India) under the 12th Five Year Plan project Affordable Cancer Therapeutics (ACT) [CSC0301]
  2. University Grant Commission (UGC), Delhi
  3. International Scientific Partnership Program ISPP at King Saud University [0054]

Ask authors/readers for more resources

A series of new podophyllotoxin linked beta-carboline congeners have been synthesized by coupling various substituted beta-carboline acids with 4 beta-aminopodophyllotoxin. Evaluation of their anticancer activity against a panel of human cancer cell lines such as lung cancer (A549), prostate cancer (DU-145), MDA MB-231 (breast cancer), HT-29 (colon cancer) and HeLa (cervical cancer) suggested that 7i and 7j are the most cytotoxic compounds with IC50 values of 1.07 +/- 0.07 mu M and 1.14 +/- 0.16 respectively against DU-145 cell line. Further, detailed biological studies such as cell cycle analysis, topoisomerase II inhibition, Comet assay, DNA binding studies and docking studies have revealed that these congeners are DNA interacting topoisomerase II inhibitors. (C) 2017 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available